BioStem Technologies (OTCQB: BSEM)

@BSEM_Tech

BioStem Technologies provides innovative perinatal tissue allografts for use in regenerative therapies. $BSEM

Fort Lauderdale, FL

biostemtechnologies.com

Joined July 2020

BioStem Technologies (OTCQB: BSEM)
@BSEM_Tech
Aug 13
We’re excited to unveil the newly redesigned BioStem Technologies website—built to better reflect who we are today and where we’re headed. Visit hubs.ly/Q04sX8K40 and explore what’s new. #BioStemTechnologies #WoundCare #SurgicalCare #TissueAllografts #BioRetain #CryoTek
BioStem Technologies (OTCQB: BSEM)
@BSEM_Tech
Aug 12
BioStem Technologies (Nasdaq: BSEM) has announced its Second Quarter 2026 financial results, reflecting continued progress across our business and another important step forward in our growth strategy. hubs.ly/Q04sShvx0 #BioStemTechnologies #BSEM #Nasdaq
BioStem Technologies (OTCQB: BSEM)
@BSEM_Tech
Aug 12
Join us on today, August 12 at 4:30 PM ET as BioStem Technologies® hosts our Second Quarter 2026 Financial Results Conference Call and Webcast. Our management team will provide an update on the quarter and discuss the Company's continued progress. 📅 August 12, 2026 🕟 4:30 PM
BioStem Technologies (OTCQB: BSEM)
@BSEM_Tech
Aug 7
🎉 First Trade! Today marks a defining moment in BioStem Technologies®' history. We are proud to announce that BioStem Technologies is now trading on the Nasdaq Capital Market under the ticker: BSEM. hubs.ly/Q04scKB30 #FirstTrade #Nasdaq $BSEM #BioStem
BioStem Technologies (OTCQB: BSEM)
@BSEM_Tech
Aug 6
We are proud to announce that BioStem Technologies® has been approved for listing on the Nasdaq Capital Market. Beginning August 7, 2026, our common stock is expected to trade on Nasdaq under our existing ticker symbol: BSEM. Full release: hubs.ly/Q04sbMxw0 #Nasdaq #BSEM